137 related articles for article (PubMed ID: 24573226)
1. Allelic methylation status of CpG islands on chromosome 21q in patients with Trisomy 21.
Xia YY; Ding YB; Liu XQ; Chen XM; Cheng SQ; Li LB; Ma MF; He JL; Wang YX
Mol Med Rep; 2014 May; 9(5):1681-8. PubMed ID: 24573226
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive analysis of allelic methylation status of CpG islands on human chromosome 21q.
Yamada Y; Watanabe H; Miura F; Soejima H; Uchiyama M; Iwasaka T; Mukai T; Sakaki Y; Ito T
Genome Res; 2004 Feb; 14(2):247-66. PubMed ID: 14762061
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive analysis of allelic methylation status of CpG islands on human chromosome 11q: comparison with chromosome 21q.
Yamada Y; Shirakawa T; Taylor TD; Okamura K; Soejima H; Uchiyama M; Iwasaka T; Mukai T; Muramoto K; Sakaki Y; Ito T
DNA Seq; 2006 Aug; 17(4):300-6. PubMed ID: 17312950
[TBL] [Abstract][Full Text] [Related]
4. Systematic search for placental DNA-methylation markers on chromosome 21: toward a maternal plasma-based epigenetic test for fetal trisomy 21.
Chim SS; Jin S; Lee TY; Lun FM; Lee WS; Chan LY; Jin Y; Yang N; Tong YK; Leung TY; Lau TK; Ding C; Chiu RW; Lo YM
Clin Chem; 2008 Mar; 54(3):500-11. PubMed ID: 18202156
[TBL] [Abstract][Full Text] [Related]
5. Factors to preserve CpG-rich sequences in methylated CpG islands.
Miyahara H; Hirose O; Satou K; Yamada Y
BMC Genomics; 2015 Feb; 16(1):144. PubMed ID: 25879481
[TBL] [Abstract][Full Text] [Related]
6. Massive parallel bisulfite sequencing of CG-rich DNA fragments reveals that methylation of many X-chromosomal CpG islands in female blood DNA is incomplete.
Zeschnigk M; Martin M; Betzl G; Kalbe A; Sirsch C; Buiting K; Gross S; Fritzilas E; Frey B; Rahmann S; Horsthemke B
Hum Mol Genet; 2009 Apr; 18(8):1439-48. PubMed ID: 19223391
[TBL] [Abstract][Full Text] [Related]
7. Isolation and enrichment of human genomic CpG islands by methylation-sensitive mirror orientation selection.
Huang Q; Baum L; Huang JF; You JP; Wang F; Wang J; Zheng J; Yan XC; Xia H; Zhao YH; Kuang H; Fu WL
Anal Biochem; 2007 Jun; 365(2):153-64. PubMed ID: 17481566
[TBL] [Abstract][Full Text] [Related]
8. Non-invasive detection of fetal trisomy 21 using fetal epigenetic biomarkers with a high CpG density.
Lim JH; Lee DE; Kim KS; Kim HJ; Lee BY; Park SY; Ahn HK; Lee SW; Kim MY; Ryu HM
Clin Chem Lab Med; 2014 May; 52(5):641-7. PubMed ID: 24353143
[TBL] [Abstract][Full Text] [Related]
9. Trisomy 21 Alters DNA Methylation in Parent-of-Origin-Dependent and -Independent Manners.
Alves da Silva AF; Machado FB; Pavarino ÉC; Biselli-Périco JM; Zampieri BL; da Silva Francisco Junior R; Mozer Rodrigues PT; Terra Machado D; Santos-Rebouças CB; Gomes Fernandes M; Chuva de Sousa Lopes SM; Lopes Rios ÁF; Medina-Acosta E
PLoS One; 2016; 11(4):e0154108. PubMed ID: 27100087
[TBL] [Abstract][Full Text] [Related]
10. Application of Differentially Methylated Loci in Clinical Diagnosis of Trisomy 21 Syndrome.
Zhang R; Yin Y; Zhang S; Chen L; Pu L; Deng Q; Zhang H; Xiao L
Genet Test Mol Biomarkers; 2019 Apr; 23(4):246-250. PubMed ID: 30986102
[TBL] [Abstract][Full Text] [Related]
11. Highly efficient PCR assay to discriminate allelic DNA methylation status using whole genome amplification.
Yamada Y; Ito T
BMC Res Notes; 2011 Jun; 4():179. PubMed ID: 21663670
[TBL] [Abstract][Full Text] [Related]
12. Effects of genome architecture and epigenetic factors on susceptibility of promoter CpG islands to aberrant DNA methylation induction.
Takeshima H; Yamashita S; Shimazu T; Ushijima T
Genomics; 2011 Sep; 98(3):182-8. PubMed ID: 21683780
[TBL] [Abstract][Full Text] [Related]
13. A distinct group of CpG islands shows differential DNA methylation between replicas of the same cell line in vitro.
Cocozza S; Scala G; Miele G; Castaldo I; Monticelli A
BMC Genomics; 2013 Oct; 14():692. PubMed ID: 24106769
[TBL] [Abstract][Full Text] [Related]
14. Novel Epigenetic Markers on Chromosome 21 for Noninvasive Prenatal Testing of Fetal Trisomy 21.
Lee DE; Lim JH; Kim MH; Park SY; Ryu HM
J Mol Diagn; 2016 May; 18(3):378-387. PubMed ID: 26947512
[TBL] [Abstract][Full Text] [Related]
15. Evolutionary origin and methylation status of human intronic CpG islands that are not present in mouse.
Rademacher K; Schröder C; Kanber D; Klein-Hitpass L; Wallner S; Zeschnigk M; Horsthemke B
Genome Biol Evol; 2014 Jun; 6(7):1579-88. PubMed ID: 24923327
[TBL] [Abstract][Full Text] [Related]
16. Fundamental diversity of human CpG islands at multiple biological levels.
Zeng J; Nagrajan HK; Yi SV
Epigenetics; 2014 Apr; 9(4):483-91. PubMed ID: 24419148
[TBL] [Abstract][Full Text] [Related]
17. Techniques used in studies of age-related DNA methylation changes.
Wojdacz TK; Hansen LL
Ann N Y Acad Sci; 2006 May; 1067():479-87. PubMed ID: 16804030
[TBL] [Abstract][Full Text] [Related]
18. Comparative genome-wide DNA methylation analysis in myocardial tissue from donors with and without Down syndrome.
Cejas RB; Wang J; Hageman-Blair R; Liu S; Blanco JG
Gene; 2021 Jan; 764():145099. PubMed ID: 32861879
[TBL] [Abstract][Full Text] [Related]
19. CpG islands: algorithms and applications in methylation studies.
Zhao Z; Han L
Biochem Biophys Res Commun; 2009 May; 382(4):643-5. PubMed ID: 19302978
[TBL] [Abstract][Full Text] [Related]
20. Aberrant hTERT promoter methylation predicts prognosis in Chinese patients with acral and mucosal melanoma: A CONSORT-compliant article.
Xu H; Wang W; Zhao J; Li T; Kang X
Medicine (Baltimore); 2019 Oct; 98(43):e17578. PubMed ID: 31651862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
